Study Raises Questions About Prostate Cancer Therapies Targeting IGF-1

Thursday, May 1, 2008 - 06:21 in Health & Medicine

Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor to activate its target receptor could have unexpected results especially if a major tumor suppressor gene -- p53 -- is already compromised.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net